Phylogica Ltd, a public Australian drug discovery company, announced that they have entered into an agreement with MedImmune to evaluate Phylogica’s proprietary Phylomer peptide library for novel antimicrobial peptides.
Shares of Jazz Pharmaceuticals Inc. jumped after federal health officials said one of its drugs appears effective for treating a chronic pain disorder.
A special set of sugars found on some disease-causing pathogens helps those pathogens fight the body's natural defenses as well as vaccines, say two Iowa State University researchers.
A team of scientists published results of a study that suggests new ways in which tumor cells develop resistance to one of the most successful targeted therapies, the small-molecule drug Tarceva.
Tanner Pharmaceuticals Inc. announced that it has entered into an exclusive agreement with the Chao Center for the rights to distribute cycloserine, a drug to treat multidrug-resistant tuberculosis, in the Latin American market.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has sold its royalty interest in CIMZIA marketed by UCB S.A. for $4 million to an undisclosed buyer.
Xenon Pharmaceuticals Inc. announced that it has initiated a phase 2 clinical trial evaluating its novel topical XEN402 therapy for the treatment of postherpetic neuralgia.
Abbott announced that the U.S. Food and Drug Administration approved the supplemental New Drug Application for CREON Delayed-Release Capsules that now includes dosing guidance specific to patients with exocrine pancreatic insufficiency.
NephRx Corporation announced that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product NX001 for the prevention of delayed graft function in renal transplant recipients.
Shire PLC said it will pull a blood-pressure drug off the market following warnings from federal regulators who said the drug has not been proven effective.
Oxford Expression Technologies, a specialist provider of baculovirus-based protein expression solutions, launches pOET3, a novel baculovirus transfer plasmid for improved expression of glycosylated, secreted, and membrane-targeted proteins.
Chronix Biomedical reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany’s first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen.
After evaluating multiple service providers, Bioo Scientific chose Eureka Genomics as its next-generation sequencing service provider based on their extensive sequencing experience, quick turnaround times, and strong bioinformatics support.
A recently released double-blind trial showed that the antidepressant Pristiq can alleviate symptoms of major depression in women experiencing or about to experience menopause.
Building on an enzyme found in nature, researchers have created a nanoscale coating for surgical equipment, hospital walls, and other surfaces which safely eradicates methicillin resistant Staphylococcus aureus, the bacteria responsible for antibiotic resistant infections.